Description
What Herceptin is?
Herceptin is a HER2/neu receptor antagonist indicated for:
• The treatment of HER2-overexpressing breast cancer.
• The treatment of HER2-overexpressing metastatic gastric orgastroesophageal junction adenocarcinoma.
Select patients for therapy based on an FDA-approved companion diagnostic for Herceptin.
What trastuzumab is?
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.
What are the Alternate Brands of Trastuzumab?
- Trasmab™ By Aureate Healthcare.
- Herceptin By Genentech
- Hertraz By Mylan
- Eleftha By Intas
- CanMab By Biocon
- Vivitra By Zydus
- Herclon By Roche
- Trasturel By Reliance
- Biceltis By Emucure
